Qilian International - תחזית צמיחת רווח נקי למניה לשנה הבאה QLI

Delisting risks and US-China trade barriers are weighing on Qilian International (QLI) shares. Shifts in analyst EPS growth estimates reflect the current trend, where the parameter value equals 0.00. Revenues are based on the sale of herbal extracts and heparin through pharmacies. Supply stability is ensured by regional hubs that optimize the procurement of botanical raw materials for the plants.

This growth benchmark for next year's net income per share reflects the analysts' consensus forecast regarding EPS growth rates, enabling the timely detection of asset overvaluation following earnings reports. For Qilian International (QLI), this trend confirms the effectiveness of production line modernization and expansion into the veterinary sector, transforming estimated profit expectations into an objective indicator of the business's fundamental stability.